1. Discovery of δ Opioid Receptor Full Inverse Agonists and Their Effects on Restraint Stress-Induced Cognitive Impairment in Mice
- Author
-
Toru Nemoto, Kennosuke Itoh, Hideaki Fujii, Takashi Iwai, Chiharu Iwamatsu, Mitsuo Tanabe, Eika Higashi, Shigeto Hirayama, and Minami Nakamura
- Subjects
Male ,Restraint, Physical ,medicine.medical_specialty ,Drug Inverse Agonism ,Physiology ,medicine.drug_class ,Cognitive Neuroscience ,Biochemistry ,Mice ,03 medical and health sciences ,Cognition ,0302 clinical medicine ,Opioid receptor ,Receptors, Opioid, delta ,Internal medicine ,medicine ,Animals ,Inverse agonist ,Cognitive Dysfunction ,Cognitive impairment ,030304 developmental biology ,0303 health sciences ,Behavior, Animal ,business.industry ,Antagonist ,Cell Biology ,General Medicine ,Analgesics, Opioid ,Memory, Short-Term ,Endocrinology ,Restraint stress ,business ,Stress, Psychological ,030217 neurology & neurosurgery - Abstract
The cyclopropylmethyl group in classical δ opioid receptor (DOR) antagonist NTI, BNTX, and NTB was replaced with various electron-withdrawing groups to develop DOR inverse agonists. N-Benzyl NTB derivative SYK-657 was a potent DOR full inverse agonist and its potency was over 10-fold potent than that of a reference compound ICI-174,864. Intraperitoneal administration of SYK-657 induced the short-term memory improving effect in mice without abnormal behaviors.
- Published
- 2019